IL22 and chronic obstructive pulmonary disease: In line with this, human patients with COPD have higher sputum IL-17 than non-smoking controls (85), and IL-17-, IL-22-, and IL-23-expressing cells are increased in bronchial biopsies from COPD patients (81).